NIGHTSTAR THERAPEUTICS PLC's ticker is NITE and the CUSIP is 65413A101. A total of 30 filers reported holding NIGHTSTAR THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $5,318,000 | – | 260,278 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,768,946 | $25,420,000 | 0.98% |
| NEA Management Company, LLC | 714,285 | $10,221,000 | 0.46% |
| PFM Health Sciences, LP | 1,009,973 | $14,453,000 | 0.29% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 122,074 | $1,747,000 | 0.23% |
| Partner Investment Management, L.P. | 10,412 | $149,000 | 0.16% |
| Tourbillon Capital Partners, L.P. | 170,952 | $2,446,000 | 0.10% |
| ASCEND CAPITAL, LLC | 120,981 | $1,730,000 | 0.07% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 34,169 | $489,000 | 0.04% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 49,663 | $711,000 | 0.02% |
| Alyeska Investment Group, L.P. | 123,884 | $1,773,000 | 0.02% |